copyright 1 MG-SEMAGLUTIDE for Dummies
The demo obtained both equally its primary endpoints, with semaglutide two.four mg demonstrating statistically considerable and exceptional improvements in liver fibrosis without having worsening of steatohepatitis, and resolution of steatohepatitis with no worsening of liver fibrosis in individuals with MASH when compared with placebo.1Quite a few